Handling Informative Premature Treatment or Study Discontinuation for Assessing Between-Group Differences in a Comparative Oncology Trial

被引：3
|
作者：
Huang, Bo [1 ]
Sun, Ryan [2 ,3 ]
Claggett, Brian [4 ]
Tian, Lu [5 ]
Ludmir, Ethan B. [2 ,3 ,6 ]
Wei, Lee-Jen [7 ]
机构：
[1] Pfizer Inc, Groton, CT 06340 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[3] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA
[4] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA
[5] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Palo Alto, CA 94304 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Radiat Oncol, Houston, TX 77030 USA
[7] Harvard Univ, Dept Biostat, 655 Huntington Ave, Boston, MA 02115 USA
来源：
JAMA ONCOLOGY | 2022年 / 8卷 / 10期
基金：
美国国家卫生研究院;
关键词：
D O I：
10.1001/jamaoncol.2022.2394
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1502 / 1503
页数：2
相关论文
共 50 条
  • [21] Phase II Trial of Bevacizumab in the Treatment of Persistent or Recurrent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
    Monk, Bradley J.
    Sill, Michael W.
    Burger, Robert A.
    Gray, Heidi J.
    Buekers, Thomas E.
    Roman, Lynda D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (07) : 1069 - 1074
  • [22] A phase II trial of merbarone (NSC 336628) in the treatment of recurrent epithelial ovarian carcinoma - A Gynecologic Oncology Group Study
    Look, KY
    Blessing, JA
    Adelson, MD
    Morris, M
    Bookman, MA
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (01): : 7 - 9
  • [23] Phase II trial of combination bevacizumab and temsirolimus in the treatment of recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study
    Alvarez, E.
    Brady, W.
    Walker, J.
    Rotmensch, J.
    Zhou, X.
    Kendrick, J.
    Yamada, S.
    Aghajanian, C.
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 125 : S17 - S17
  • [24] A phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: A children's oncology group study
    Horton, Terzah M.
    Ames, Matthew M.
    Reid, Joel M.
    Krailo, Mark D.
    Pendergrass, Thomas
    Mosher, Revonda
    Reaman, Gregory H.
    Seibel, Nita L.
    [J]. PEDIATRIC BLOOD & CANCER, 2008, 50 (04) : 788 - 792
  • [25] Phase II trial of combination bevacizumab and temsirolimus in the treatment of A recurrent or persistent endometrial carcinoma: A Gynecologic Oncology Group study
    Alvarez, Edwin A.
    Brady, William E.
    Walker, Joan L.
    Rotmensch, Jacob
    Zhou, Xun C.
    Kendrick, James E.
    Yamada, S. Diane
    Schilder, Jeanne M.
    Cohn, David E.
    Harrison, Charles R.
    Moore, Kathleen N.
    Aghajanian, Carol
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 129 (01) : 22 - 27
  • [26] PHASE-II TRIAL OF ESORUBICIN IN THE TREATMENT OF METASTATIC CARCINOMA OF THE KIDNEY - A STUDY OF THE NORTHERN-CALIFORNIA-ONCOLOGY-GROUP
    CARLSON, RW
    WILLIAMS, RD
    BILLINGHAM, ME
    KOHLER, M
    TORTI, FM
    [J]. CANCER TREATMENT REPORTS, 1987, 71 (7-8): : 767 - 768
  • [27] Patient-Reported Outcomes in a Randomized Trial of Bevacizumab in the Treatment of Advanced Cervical Cancer: a Gynecologic Oncology Group Study
    Penson, Richard T.
    Huang, Helen Q.
    Wenzel, Lari
    Tewari, Krishnansu
    Monk, Bradley J.
    Sill, Michael
    Stockman, Sharon
    Ramondetta, Lois
    Landrum, Lisa
    Oaknin, Ana
    Reid, Thomas
    Leitao, Mario
    [J]. QUALITY OF LIFE RESEARCH, 2014, 23 : 68 - 68
  • [28] PHASE-II TRIAL OF ADRIAMYCIN IN THE TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BUCHSBAUM, HJ
    MANGAN, C
    BLESSING, JA
    [J]. CANCER TREATMENT REPORTS, 1979, 63 (01): : 21 - 27
  • [29] PHASE-II TRIAL OF PIPERAZINEDIONE IN THE TREATMENT OF ADVANCED OR RECURRENT ENDOMETRIAL CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    THIGPEN, JT
    BLESSING, JA
    HOMESLEY, HD
    PETTY, W
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (01): : 21 - 23
  • [30] A comparative study of the efficacy of group positive psychotherapy and group cognitive behavioral therapy in the treatment of depressive disorders: A randomized controlled trial
    Furchtlehner, Linda Maria
    Schuster, Raphael
    Laireiter, Anton-Rupert
    [J]. JOURNAL OF POSITIVE PSYCHOLOGY, 2020, 15 (06): : 832 - 845
12345